4-carboxyfluorescein has been researched along with busulfan in 1 studies
| Studies (4-carboxyfluorescein) | Trials (4-carboxyfluorescein) | Recent Studies (post-2010) (4-carboxyfluorescein) | Studies (busulfan) | Trials (busulfan) | Recent Studies (post-2010) (busulfan) |
|---|---|---|---|---|---|
| 116 | 0 | 53 | 4,967 | 645 | 1,426 |
| Protein | Taxonomy | 4-carboxyfluorescein (IC50) | busulfan (IC50) |
|---|---|---|---|
| Matrix metalloproteinase-9 | Homo sapiens (human) | 5.215 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, BS; Hassan, M; Valdez, BC | 1 |
1 other study(ies) available for 4-carboxyfluorescein and busulfan
| Article | Year |
|---|---|
Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions.
Topics: Antineoplastic Agents, Alkylating; Biological Transport; Busulfan; Cell Line, Tumor; Cell Survival; Chlorambucil; Cyclophosphamide; Drug Interactions; Ethacrynic Acid; Everolimus; Flow Cytometry; Fluoresceins; Humans; Ketoconazole; Melphalan; Multidrug Resistance-Associated Proteins; Reproducibility of Results; Sirolimus | 2017 |